Fox Chase Cancer Center News

PHILADELPHIA (April 24, 2020) – Christian Koch, MD, PhD, FACP, MACE, a professor in the Department of Medicine and director for the Division of Endocrinology at Fox Chase Cancer Center, was recently named a review editor for Frontiers in Cancer Endocrinology, a specialty section in the journal Frontiers in Endocrinology.

PHILADELPHIA (April 23, 2020)— The grant was awarded to Israel Cañadas, PhD by the Lung Cancer Research Foundation to study how different cancer cells within a tumor may affect the environment around it and the tumor’s response to therapy.

PHILADELPHIA (April 21, 2020)—A clinical trial headed by Fox Chase Cancer Center physicians has found that patients with certain common benign, spontaneous kidney tumors saw a marked decrease in tumor volume after being treated with the drug everolimus, also known by its brand name, Afinitor. Until this study, there were no data on whether the drug was effective and safe for patients with the tumors who don’t have angiomyolipomas.

PHILADELPHIA (April, 20, 2020)—Researchers at Fox Chase Cancer Center were recently awarded a federally funded grant to study variability in scans for pancreatic neuroendocrine tumor (NET) patients. With repurposing of these imaging studies, which were obtained as a part of a clinical trial funded by the National Cancer Institute, researchers could begin developing solutions to these barriers.

PHILADELPHIA (April 17, 2020) — A  $2.3 million grant for a multicenter randomized clinical trial to study the use of medically tailored meals and individually-tailored nutrition counseling as part of care for lung cancer patients will enroll 150 newly diagnosed stage I-IV lung cancer patients from vulnerable populations, including those who are uninsured, economically disadvantaged, older adults, rural residents or racial/ethnic minorities.

PHILADELPHIA (April 15, 2020) – A study on partial nephrectomy techniques by Alexander Kutikov, MD, FACS, was recently published after years of collaboration involving centers in the United States and Europe. The study examined how the resection technique used during partial nephrectomy might affect operative outcomes and surgical margins

PHILADELPHIA (April 14, 2020) – Fox Chase Cancer Center announces the hiring of Andres F. Correa, MD, who will join the department of surgery in the Urologic Oncology Division. Correa was a Society of Urologic Oncology Fellow at Fox Chase.

PHILADELPHIA (April 6, 2020)—A recently published protocol paper by researchers at Fox Chase Cancer Center describes a new trial evaluating a couple-based intervention program designed to improve sexual relationships for breast cancer survivors. The goal of the study is to see whether a four-session couple-based intervention program done over the phone can help improve sexual function for breast cancer survivors.